ZA911956B - 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances - Google Patents
9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substancesInfo
- Publication number
- ZA911956B ZA911956B ZA911956A ZA911956A ZA911956B ZA 911956 B ZA911956 B ZA 911956B ZA 911956 A ZA911956 A ZA 911956A ZA 911956 A ZA911956 A ZA 911956A ZA 911956 B ZA911956 B ZA 911956B
- Authority
- ZA
- South Africa
- Prior art keywords
- clathrates
- chlor
- prostaglandin
- cyclodextrin
- beta
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4008925A DE4008925A1 (de) | 1990-03-16 | 1990-03-16 | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA911956B true ZA911956B (en) | 1991-12-24 |
Family
ID=6402643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA911956A ZA911956B (en) | 1990-03-16 | 1991-03-15 | 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0447015A1 (xx) |
AU (1) | AU7499091A (xx) |
DE (1) | DE4008925A1 (xx) |
IE (1) | IE910901A1 (xx) |
PT (1) | PT97067A (xx) |
WO (1) | WO1991013634A1 (xx) |
ZA (1) | ZA911956B (xx) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4229050A1 (de) * | 1992-08-31 | 1994-03-03 | Schering Ag | Neue 9-Chlor-Prostaglandin-Ester und -amide |
EP0656889B1 (de) * | 1992-08-31 | 1998-05-27 | Schering Aktiengesellschaft | 9-chlor-prostaglandin-ester und -amide und ihre verwendung für die herstellung von arzneimitteln |
NZ330596A (en) | 1998-06-05 | 2001-02-23 | Dec Res | Intravaginal devices allowing for increased uptake of active ingredients |
FR2799375B1 (fr) | 1999-10-07 | 2002-01-18 | Marc Brunel | Dispositif d'injection a usage unique |
FR2971424B1 (fr) | 2011-02-14 | 2013-11-29 | Marc Brunel | Seringue de securite |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504044A1 (de) * | 1985-02-04 | 1986-08-07 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel |
ES2054860T5 (es) * | 1987-07-17 | 2003-11-01 | Schering Ag | Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos. |
-
1990
- 1990-03-16 DE DE4008925A patent/DE4008925A1/de not_active Withdrawn
-
1991
- 1991-03-15 EP EP91250078A patent/EP0447015A1/de not_active Withdrawn
- 1991-03-15 WO PCT/DE1991/000236 patent/WO1991013634A1/de unknown
- 1991-03-15 ZA ZA911956A patent/ZA911956B/xx unknown
- 1991-03-15 AU AU74990/91A patent/AU7499091A/en not_active Abandoned
- 1991-03-18 PT PT97067A patent/PT97067A/pt not_active Application Discontinuation
- 1991-03-19 IE IE090191A patent/IE910901A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT97067A (pt) | 1991-10-31 |
AU7499091A (en) | 1991-10-10 |
EP0447015A1 (de) | 1991-09-18 |
IE910901A1 (en) | 1991-09-25 |
DE4008925A1 (de) | 1991-09-19 |
WO1991013634A1 (de) | 1991-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0475434A3 (en) | Polymer composition and its use | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
ZA929127B (en) | Quinoline-3-carboxamides their manufacture and use | |
EP0304802A3 (en) | Pharmaceutical composition and the use thereof | |
IL97122A0 (en) | Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them | |
EP0482649A3 (en) | Cm-chitin derivatives and use thereof | |
ZA929128B (en) | Hydroxypyridonecarboxamides their manufacture and use | |
ZA903409B (en) | Maleinimide-derivatives and their use as pharmaceuticals | |
GB8919726D0 (en) | Ws7338 substances and preparation thereof | |
EP0465132A3 (en) | Dna and its use | |
ZA959904B (en) | Iminooxymethyleneanilides thei preparation and their use | |
ZA9110045B (en) | Pyrimidinyl-and triazinyl-salicylamides and their use and preparation | |
ZA911956B (en) | 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances | |
ZA911065B (en) | Chemical and pharmaceutical compositions | |
HU9204072D0 (en) | Terazole derivatives and medical preparatives containing them | |
GB9016027D0 (en) | Composition and use | |
IL97366A (en) | Aryl-propyl-amines their preparation and their use as fungicides | |
IL114161A0 (en) | Amido- quinoxalinediones pharmaceutical compositions containing them and their use | |
IL105873A0 (en) | Pyrimidinyl-and triazinyl-salicyl-and-picolyl-amides and the use and preparation thereof | |
ZA935119B (en) | Medicinal composition comprising TCF-II | |
GB9000241D0 (en) | Pharmaceutical use | |
HU9203050D0 (en) | Thieno-cyclopentanole-oximes and pharmaceutical preparatives containing them | |
ZA942246B (en) | Novel imidazolo-quinoxalinones their preparation and use | |
ZA928419B (en) | Pharmaceutical substances or compositions and their use | |
GB9001318D0 (en) | Wb968 substances and preparation thereof |